The adenosine A2a receptor (A2aAR) gene is thought to be involved in essential hypertension because adenosine elicits vasodilation and decreases arterial blood pressure via this receptor, and because disruption of the A2aAR gene increases blood pressure in mice. Therefore, using a restriction fragment length polymorphism (RFLP) of the A2aAR gene, we performed an association study in patients with essential hypertension. One hundred forty-two patients with essential hypertension and 142 age-matched subjects with normal blood pressure were studied. Polymerase chain reaction (PCR) was applied to amplify the T1083C polymorphic site in the A2aAR gene, and restriction analysis of the PCR product was employed to score the T and C alleles. Overall distributions of allele frequencies in the two groups were not significantly different. Thus, the alleles detected by this RFLP polymorphism in the A2aAR gene are not associated with essential hypertension. Am
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KEY WORDS: Association study, essential hypertension, adenosine A2a receptor, genetics. E ssential hypertension (EH) is a complex, polygenic disease. Association studies using the candidate gene approach may provide important clues regarding the etiology of hypertension and define the basis for further genetic investigation. 1 Recently, the human adenosine A2a receptor (A2aAR) gene has been localized to chromosome 22q11.2.
2,3 and a polymorphism T1083C has been identified at the third base position of codon 361. 3, 4 In most animals, administration of adenosine results in profound hypotension without the expected activation of reflex sympathetic mechanisms. 5 A selective A2aAR agonist has a potent and long-lasting antihypertensive effect in spontaneously hypertensive rats (SHR) 6, 7 and in Dahl salt-sensitive rats. 8 An A2aAR antagonist blocks the ability of smooth muscle cellderived adenosine to inhibit cell growth. 9 Therefore, the adenosine-A2aAR system may be involved in regulating blood pressure. Furthermore, Ledent et al reported that disruption of the A2aAR gene increased blood pressure, heart rate, and platelet aggregation in mice. 10 We therefore examined the relation between a T1083C polymorphism in exon 2 of the A2aAR gene and EH in Japanese individuals.
MATERIALS AND METHODS

Subjects
The study population included 142 individuals with EH (EH group; age, 49.4 Ϯ 9.2 years [mean Ϯ SD]) diagnosed according to the World Health Organization criteria. These criteria include a sitting systolic blood pressure (SBP) or diastolic blood pressure (DBP) of Ն 160 or Ն 95 mm Hg, respectively, on three occasions spanning 2 months after the first medical examination, during which time no antihypertensive drugs were administered. Subjects diagnosed with secondary hypertension were excluded. A total of 142 normotensive healthy age-and gendermatched subjects (NT group; age 49.2 Ϯ 10.0 years) served as controls. The NT subjects had no family history of hypertension and, in all instances, their SBP and DBP were Ͻ 140 mm Hg and Ͻ 85 mm Hg, respectively. A positive family history was defined as hypertension diagnosed in grandparents, uncles, aunts, parents, or siblings. Both patients and controls were recruited from northern Tokyo, and informed consent was obtained from each individual according to a protocol approved by the Human Studies Committee of Nihon University.
Biochemical Analysis
The plasma concentration of total cholesterol, and the serum concentrations of creatinine and uric acid were measured by standard methods in the clinical laboratory department of the university hospital.
Analysis of the A2aAR Gene Restriction Fragment
Length Polymorphism Genomic DNA was extracted from peripheral blood leukocytes by standard methods. A restriction fragment length polymorphism (RFLP) assay was developed to detect a C to T transition at nucleotide 1083 in exon 2 of the human A2aAR gene according to the method reported by Decker et al. 11 Because the 1083 T/C polymorphism does not alter a natural restriction site, we used a mutagenic primer (F2; 5Ј-CTGAGCGGAGGCCCAATGGGTA-3Ј; nucleotide substitution is underlined) to introduce an Rsa1 restriction site. Amplification with forward primer F2 and reverse primer R2 (5Ј-CTCCCAACGT-GACTGGTCAAG-3Ј) resulted in a 256-base pair (bp) polymerase chain reaction (PCR) fragment. Depending on the absence or presence of the polymorphic Rsa1 restriction site, either one 256-bp fragment (1083T) or two fragments of 234 and 22 bp (1083C) are produced. PCR was performed in a 40 L total reaction volume containing 100 ng of genomic DNA according to the manufacture's specifications (TaKaRa Ex Taq, Takara Shuzo Co., Ltd., Tokyo, Japan). After an initial 5-min denaturation at 95°C, 35 cycles were carried out, consisting of 30 sec at 94°C, 30 sec at 66°C, and 30 sec at 72°C, followed by a final extension step of 5 min at 72°C. A PCR product was extracted by ethanol precipitation, and a 20-L aliquot was incubated overnight with 1 U of Rsa1 according to the manufacture's recommendations (BioLabs Inc.). Fragments were separated in a 1.5% agarose gel and visualized by ethidium bromide staining.
Statistical Analysis Data are presented as mean Ϯ SD. Allele frequencies were calculated from the genotypes of all subjects. Hardy-Weinberg equilibrium was assessed by 2 analysis. The significance of the difference between the total number of alleles on all chromosomes for the EH and NT groups was assessed by 2 analysis with one degree of freedom. Difference in the clinical data between the EH and NT groups were assessed by analysis of variance followed by a Fisher's protected least-significant difference test. A P Ͻ .05 was considered significant.
RESULTS
Genotypes of T/T, T/C
, and C/C were detected with frequencies of 0.592 (84/142), 0.387 (55/142) and 0.021 (3/142) in the NT group, and of 0.627 (89/142), 0.303 (43/142), and 0.070 (10/142) in the EH group, respectively. The genotype distribution was in Hardy-Weinberg equilibrium ( 2 ϭ 0.05, P Ͼ .1) and was not significantly different between the NT and EH groups. The frequencies of the T and C alleles were 78.5% (223/284) and 21.5% (61/284) for the NT group and 77.8% (221/284) and 22.2% (63/284) for the EH group, respectively, and did not differ significantly between the two groups.
The clinical characteristics of the EH and NT subjects are shown in Table 1 . SBP, DBP, pulse rate, and BMI were significantly higher in the EH than in the NT group. There were no significant differences in age, gender, or in serum concentrations of creatinine and uric acid, or in plasma concentrations of total and HDL cholesterol between the two groups. 
DISCUSSION
In this study, the presence of a T1083C polymorphism in the A2aAR gene did not correlate with EH. A T1083C variant is the only common coding frame polymorphism in the A2aAR gene. 4 We found that the C allele was much less frequent than that reported by Decker et al 4 and Le et al, 3 as shown in Table 2 . This discrepancy may be attributable to ethnic differences as observed in angiotensinogen 12 and the endothelial nitric oxide synthase gene. 13, 14 In association analyses using a genetic marker, subject selection is a critical, but difficult, problem. Given that blood pressure is influenced by age, we selected closely age-matched subjects in the normotensive and hypertensive groups. Additionally, we strictly defined normotensive human subjects and omitted anyone whose blood pressure was raised even slightly or whose family history was EH positive because such individuals might become hypertensive later in life. We also omitted borderline hypertensive subjects.
There was no significant difference in allele frequencies between the age-matched normotensive and hypertensive groups, leaving little chance that this polymorphic marker is linked to the pathogenic EH gene. However, our negative result does not exclude the possibility of another variant elsewhere in or near the A2aAR gene in EH. 
